Brainstorm Cell Therapeut...

0.73
-0.05 (-6.17%)
At close: Apr 16, 2025, 10:14 AM

Brainstorm Cell Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-11.62M -17.19M -24.28M -24.46M -31.81M -23.25M -13.95M -4.95M -4.98M
240K 265K 285K 260K 219K 164K 110K 85K 77K
750K n/a 1.68M 1.37M 2.56M 789K 917K 554K 635K
160K -3.75M -601K -2.05M 1.61M 234K -2.46M 2.63M -1.26M
-147K 220K -1.34M n/a n/a n/a 102K 62K 121K
n/a n/a 1.34M n/a n/a n/a n/a n/a n/a
1.69M -3.75M 2.99M -3.43M -6.16M 11.05M 431K 1.89M -1.71M
-9.09M -20.46M -19.32M -26.27M -35.19M -11.25M -12.39M -2.36M -5.86M
n/a -18K -29K -330K -378K -473K -369K -180K -103K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 2.21M 1.03M n/a n/a n/a n/a n/a n/a
12K n/a 1.00 653K -4.07M 6.09M -849K 4.17M 6.08M
12K 2.19M 998K 323K -4.45M 5.62M -1.22M 3.99M 5.98M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a -116K n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a 5K 16.32M 3.16M 12.06M 314K n/a
7.97M 18.98M 238K 6.97M 76.94M 5.22M 12.06M 314K n/a
-1.11M 713K -18.08M -18.97M 37.29M -406K -1.54M 1.94M 119K
-9.09M -20.48K -19.35M -26.59M -35.57M -11.72M -12.76M -2.54M -5.96M